These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 16374252)

  • 1. Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody.
    Fuss IJ; Becker C; Yang Z; Groden C; Hornung RL; Heller F; Neurath MF; Strober W; Mannon PJ
    Inflamm Bowel Dis; 2006 Jan; 12(1):9-15. PubMed ID: 16374252
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An anti-IL-12p40 antibody down-regulates type 1 cytokines, chemokines, and IL-12/IL-23 in psoriasis.
    Toichi E; Torres G; McCormick TS; Chang T; Mascelli MA; Kauffman CL; Aria N; Gottlieb AB; Everitt DE; Frederick B; Pendley CE; Cooper KD
    J Immunol; 2006 Oct; 177(7):4917-26. PubMed ID: 16982934
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of virus-induced IL-12 and IL-23 expression in human macrophages.
    Pirhonen J; Matikainen S; Julkunen I
    J Immunol; 2002 Nov; 169(10):5673-8. PubMed ID: 12421946
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-12p40-overexpressing immature dendritic cells induce T cell hyporesponsiveness in vitro but accelerate allograft rejection in vivo: role of NK cell activation and interferon-gamma production.
    Sun W; He X; Guo Z; Wang Q; Li X; Rayner J; Zhang L; Wang J; Cao X
    Immunol Lett; 2004 Jul; 94(3):191-9. PubMed ID: 15275966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of interleukin-12-related cytokine transcripts in inflammatory bowel disease: elevated interleukin-23p19 and interleukin-27p28 in Crohn's disease but not in ulcerative colitis.
    Schmidt C; Giese T; Ludwig B; Mueller-Molaian I; Marth T; Zeuzem S; Meuer SC; Stallmach A
    Inflamm Bowel Dis; 2005 Jan; 11(1):16-23. PubMed ID: 15674109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An interleukin 12 p40-IgG2b fusion protein abrogates T cell mediated inflammation: anti-inflammatory activity in Crohn's disease and experimental colitis in vivo.
    Stallmach A; Marth T; Weiss B; Wittig BM; Hombach A; Schmidt C; Neurath M; Zeitz M; Zeuzem S; Abken H
    Gut; 2004 Mar; 53(3):339-45. PubMed ID: 14960512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro analysis of interferon gamma (IFN-gamma) and interleukin-12 (IL-12) production and their effects in ileal Crohn's disease.
    Colpaert S; Vastraelen K; Liu Z; Maerten P; Shen C; Penninckx F; Geboes K; Rutgeerts P; Ceuppens JL
    Eur Cytokine Netw; 2002; 13(4):431-7. PubMed ID: 12517728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paradoxical anti-inflammatory actions of TNF-alpha: inhibition of IL-12 and IL-23 via TNF receptor 1 in macrophages and dendritic cells.
    Zakharova M; Ziegler HK
    J Immunol; 2005 Oct; 175(8):5024-33. PubMed ID: 16210605
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of CLA, IL-12R, CD40L, and IL-2Ralpha expression and inhibition of IL-12- and IL-23-induced cytokine secretion by CNTO 1275.
    Reddy M; Davis C; Wong J; Marsters P; Pendley C; Prabhakar U
    Cell Immunol; 2007 May; 247(1):1-11. PubMed ID: 17761156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Astrocytes as antigen-presenting cells: expression of IL-12/IL-23.
    Constantinescu CS; Tani M; Ransohoff RM; Wysocka M; Hilliard B; Fujioka T; Murphy S; Tighe PJ; Das Sarma J; Trinchieri G; Rostami A
    J Neurochem; 2005 Oct; 95(2):331-40. PubMed ID: 16086689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-23 compensates for the absence of IL-12p70 and is essential for the IL-17 response during tuberculosis but is dispensable for protection and antigen-specific IFN-gamma responses if IL-12p70 is available.
    Khader SA; Pearl JE; Sakamoto K; Gilmartin L; Bell GK; Jelley-Gibbs DM; Ghilardi N; deSauvage F; Cooper AM
    J Immunol; 2005 Jul; 175(2):788-95. PubMed ID: 16002675
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
    Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
    J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-tumour necrosis factor therapy enhances mucosal healing through down-regulation of interleukin-21 expression and T helper type 17 cell infiltration in Crohn's disease.
    Liu C; Xia X; Wu W; Wu R; Tang M; Chen T; Xu F; Cong Y; Xu X; Liu Z
    Clin Exp Immunol; 2013 Jul; 173(1):102-11. PubMed ID: 23607532
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T-bet upregulation and subsequent interleukin 12 stimulation are essential for induction of Th1 mediated immunopathology in Crohn's disease.
    Matsuoka K; Inoue N; Sato T; Okamoto S; Hisamatsu T; Kishi Y; Sakuraba A; Hitotsumatsu O; Ogata H; Koganei K; Fukushima T; Kanai T; Watanabe M; Ishii H; Hibi T
    Gut; 2004 Sep; 53(9):1303-8. PubMed ID: 15306590
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced secretion of tumour necrosis factor-alpha, IL-6, and IL-1 beta by isolated lamina propria mononuclear cells from patients with ulcerative colitis and Crohn's disease.
    Reinecker HC; Steffen M; Witthoeft T; Pflueger I; Schreiber S; MacDermott RP; Raedler A
    Clin Exp Immunol; 1993 Oct; 94(1):174-81. PubMed ID: 8403503
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-IL-12/23 in Crohn's disease: bench and bedside.
    Niederreiter L; Adolph TE; Kaser A
    Curr Drug Targets; 2013 Nov; 14(12):1379-84. PubMed ID: 24138637
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Contrasting roles of IL-12p40 and IL-12p35 in the development of hapten-induced colitis.
    Camoglio L; Juffermans NP; Peppelenbosch M; te Velde AA; ten Kate FJ; van Deventer SJ; Kopf M
    Eur J Immunol; 2002 Jan; 32(1):261-9. PubMed ID: 11782017
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Type 1 T-helper cell predominance and interleukin-12 expression in the gut of patients with Crohn's disease.
    Parronchi P; Romagnani P; Annunziato F; Sampognaro S; Becchio A; Giannarini L; Maggi E; Pupilli C; Tonelli F; Romagnani S
    Am J Pathol; 1997 Mar; 150(3):823-32. PubMed ID: 9060820
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential regulation of interleukin-12 p40 and p35 induction via Erk mitogen-activated protein kinase-dependent and -independent mechanisms and the implications for bioactive IL-12 and IL-23 responses.
    Goodridge HS; Harnett W; Liew FY; Harnett MM
    Immunology; 2003 Jul; 109(3):415-25. PubMed ID: 12807488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of interleukin 18 in Crohn's disease: evidence from in vitro analysis of human gut inflammatory cells and from experimental colitis models.
    Maerten P; Shen C; Colpaert S; Liu Z; Bullens DA; van Assche G; Penninckx F; Geboes K; Vanham G; Rutgeerts P; Ceuppens JL
    Clin Exp Immunol; 2004 Feb; 135(2):310-7. PubMed ID: 14738461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.